Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Linthicum › NPI 1912329434
Supplier

University of Maryland Medical Center, LLC

University of Maryland Medical Center, LLC was paid $804K by Medicaid between Jan 2018 and Sep 2024, across 7 billing codes. Its largest line is Q0512, Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period — 56% of everything it billed.

33Billing provider infoUNIVERSITY OF MARYLAND MEDICAL CENTER, LLC
LINTHICUM, MD 21090
33aNPI1912329434assigned 01/17/2014
28Total paid$804K
24GClaims52,899
24DCodes billed7
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers

Next to other Durable Medical Equipment & Medical Supplies providers in Maryland

Rank by total paid#42 of 157
Median peer was paid$116K
This provider vs. median6.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SPRINKEL, GEORGE controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,089$430.13
20195,935$47K
20205,415$111K
20218,494$146K
202212,484$209K
20239,545$198K
2024incomplete4,937$92K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period 56% 17,144 8,842 $453K
Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period 42% 10,478 9,414 $341K
J7503 Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg <1% 3,018 1,609 $4K
J7507 Tacrolimus, immediate release, oral, 1 mg <1% 10,570 6,525 $4K
J7518 Mycophenolic acid, oral, 180 mg <1% 7,571 6,677 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,597 3,145 $109.56
J7517 Mycophenolate mofetil, oral, 250 mg 0% 521 453 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSPRINKEL, GEORGE (CFO)
Parent organizationUNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION
Same official

Other billing entities under SPRINKEL, GEORGE

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.